United States · FDA National Drug Code directory
ARISTADA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65757-404_3d951a36-1e73-4f84-8ebf-4d556d81a086
- Product NDC
- 65757-404
- Form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Composition / generic term
- aripiprazole lauroxil
- Labeler
- Alkermes, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20170605
- Source listing expiry
- 20261231
Source-listed ingredients
- ARIPIPRAZOLE LAUROXIL — 1064 mg/3.9mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (65757-404-03) / 3.9 mL in 1 SYRINGE · 65757-404-03
- 1 SYRINGE in 1 CARTON (65757-404-04) / 3.9 mL in 1 SYRINGE · 65757-404-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →